In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI),
gadopentetate dimeglumine (Magnevist®), became available for clinical use. Since then, a …

Advances in atherosclerosis imaging technology and research have provided a range of
diagnostic tools to characterize high-risk plaque in vivo; however, these important vascular …

Purpose To test the hypothesis that both coronary anatomy and ventricular function can be
assessed simultaneously using a single four‐dimensional (4D) acquisition. Methods A free …

Targeted therapies in connective tissue diseases (CTDs) have led to improvements of
disease-associated outcomes, but life expectancy remains lower compared to general …

BACKGROUND: Currently, noninvasive arteriography for the diagnosis of coronary artery
disease is clinically limited to the computed tomography scanning, where patients have to …

Background Coronary MR angiography (CMRA) at 3 T offers higher signal to noise ratio and
contrast to noise ratio compared with 1.5 T. CMRA at 5 T may provide better diagnostic …

Background Coronary artery disease (CAD) is the single most common cause of death
worldwide. Recent technological developments with coronary cardiovascular magnetic …

Purpose: To evaluate the effects of deep learning reconstruction (DLR) in qualitative and
quantitative image quality of non-contrast magnetic resonance coronary angiography …

Despite technical advances, respiratory motion remains a major impediment in a substantial
amount of patients undergoing coronary magnetic resonance angiography (CMRA) …

Objectives Whole-heart coronary magnetic resonance angiography (MRA) is a promising
non-contrast, radiation-free technique for assessing the coronary artery. Yet, a disadvantage …